UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD)

Historical Holders from Q1 2014 to Q3 2025

Symbol
UTMD on Nasdaq
Type / Class
Equity / Common Shares
Shares outstanding
3.2M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
2.16M
Holdings value
$136M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
114
Number of buys
50
Number of sells
-40
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BRANDES INVESTMENT PARTNERS, LP 10.4% +25% $18.6M $3.43M 333K +22.7% BRANDES INVESTMENT PARTNERS, LP 31 Aug 2025
RENAISSANCE TECHNOLOGIES LLC 6.7% $12.1M 231K Renaissance Technologies LLC 30 Sep 2024
DIMENSIONAL FUND ADVISORS LP 6.1% $11.2M 197K Dimensional Fund Advisors LP 30 Jun 2025
BlackRock, Inc. 5.3% +6.6% $9.83M $232K 173K +2.41% BlackRock, Inc. 30 Jun 2025
FMR LLC 2.7% $4.85M 92.4K FMR LLC 31 Dec 2024

Institutional Holders of UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 2.16M $136M +$705K $62.97 114
2025 Q2 2.15M $123M -$4.29M $56.92 109
2025 Q1 2.23M $125M -$4.05M $56.04 107
2024 Q4 2.31M $142M -$6.98M $61.47 112
2024 Q3 2.41M $161M +$1.5M $66.91 109
2024 Q2 2.4M $161M -$6.99M $66.81 99
2024 Q1 2.49M $177M -$5.99M $71.11 99
2023 Q4 2.52M $212M -$5.24M $84.22 88
2023 Q3 2.57M $221M +$1.89M $86.00 91
2023 Q2 2.55M $237M +$487K $93.20 89
2023 Q1 2.54M $241M +$8.48M $94.77 86
2022 Q4 2.55M $256M +$1.19M $100.53 81
2022 Q3 2.54M $216M -$31.3M $85.31 75
2022 Q2 2.56M $220M -$450K $85.90 74
2022 Q1 2.57M $231M -$2.81M $89.86 84
2021 Q4 2.6M $260M -$913K $100.00 78
2021 Q3 2.6M $242M +$244K $92.83 72
2021 Q2 2.6M $221M -$2.81M $85.04 68
2021 Q1 2.63M $228M +$1.01M $86.60 78
2020 Q4 2.62M $221M -$2.33M $84.30 76
2020 Q3 2.65M $212M -$2.77M $79.87 83
2020 Q2 2.68M $238M +$3.95M $88.62 91
2020 Q1 2.63M $247M -$14.1M $94.05 89
2019 Q4 2.77M $299M -$7.84M $107.90 95
2019 Q3 2.85M $273M +$14.4M $95.84 94
2019 Q2 2.7M $258M +$3.9M $95.70 96
2019 Q1 2.67M $235M -$154K $88.25 90
2018 Q4 2.68M $223M -$9.71M $83.08 85
2018 Q3 2.79M $263M +$18.7M $94.20 89
2018 Q2 2.59M $285M +$1.05M $110.15 91
2018 Q1 2.59M $256M +$9.12M $98.85 78
2017 Q4 2.5M $203M +$2.13M $81.40 78
2017 Q3 2.48M $182M +$234K $73.55 74
2017 Q2 2.48M $179M +$4.87M $72.40 75
2017 Q1 2.42M $151M +$6.33M $62.30 76
2016 Q4 2.48M $180M -$463K $72.75 75
2016 Q3 2.5M $150M -$1.27M $59.80 78
2016 Q2 2.52M $159M -$2.05M $63.00 76
2016 Q1 2.56M $160M +$3.08M $62.54 68
2015 Q4 2.53M $148M +$2.53M $58.54 65
2015 Q3 2.47M $133M -$477K $53.87 58
2015 Q2 2.47M $147M +$3.58M $59.63 63
2015 Q1 2.41M $144M -$3.61M $59.86 59
2014 Q4 2.47M $149M -$16.2K $60.05 60
2014 Q3 2.21M $108M -$11.7M $48.76 60
2014 Q2 2.43M $125M +$1.47M $51.44 60
2014 Q1 2.4M $139M +$3.54M $57.83 58